Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2409323
Max Phase: Preclinical
Molecular Formula: C28H48N4O5
Molecular Weight: 520.72
Molecule Type: Small molecule
Associated Items:
ID: ALA2409323
Max Phase: Preclinical
Molecular Formula: C28H48N4O5
Molecular Weight: 520.72
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCCCCCCn1cc(COCC23CC4CC(CC(C4)C2)C3)nn1
Standard InChI: InChI=1S/C28H48N4O5/c33-17-24-26(35)27(36)25(34)16-31(24)7-5-3-1-2-4-6-8-32-15-23(29-30-32)18-37-19-28-12-20-9-21(13-28)11-22(10-20)14-28/h15,20-22,24-27,33-36H,1-14,16-19H2/t20?,21?,22?,24-,25+,26-,27-,28?/m1/s1
Standard InChI Key: OGAHBWBWPUWLKS-NLTICPCISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 520.72 | Molecular Weight (Monoisotopic): 520.3625 | AlogP: 2.11 | #Rotatable Bonds: 14 |
Polar Surface Area: 124.10 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.90 | CX Basic pKa: 8.37 | CX LogP: 2.08 | CX LogD: 1.08 |
Aromatic Rings: 1 | Heavy Atoms: 37 | QED Weighted: 0.28 | Np Likeness Score: -0.05 |
1. Howe JD, Smith N, Lee MJ, Ardes-Guisot N, Vauzeilles B, Désiré J, Baron A, Blériot Y, Sollogoub M, Alonzi DS, Butters TD.. (2013) Novel imino sugar α-glucosidase inhibitors as antiviral compounds., 21 (16): [PMID:23582447] [10.1016/j.bmc.2013.03.014] |
Source(1):